@FiercePharma: Andrew Witty's letter to EU urges reference pricing, parallel trade changes to keep meds flowing to Greece, et al. Report | Follow @FiercePharma
> German physicians can accept gifts and junkets from drugmakers without fear of corruption allegations, a top court ruled, saying they're not state representatives but freelance workers. Report
> Sanofi ($SNY) yanked four batches of its Bacillus Calmette-Guerin tuberculosis vaccine in Australia because of questions about its sterility. Article
> Boehringer Ingelheim is scouting for over-the-counter products to buy in India, domestic media reports. Report
> Wisconsin's Supreme Court upheld a $9 million damages ruling against Pharmacia, now a unit of Pfizer ($PFE), for inflating drug prices reported to Medicaid. Report
> Amgen ($AMGN) has teamed up with actress Maura Tierney on a patient-awareness campaign about chemotherapy. Release
> European regulators said currently approved doses of the antibiotic Doribax may be strong enough to treat all patients with hospital-acquired pneumonia. Story
> Indian drugmakers have failed to respond to government charges that they overcharged for drugs. Report
Biotech News
@FierceBiotech: BIO 2012: Immunotherapies make a comeback at Big Pharma. More | Follow @FierceBiotech
@JohnCFierce: Merck Serono and Compugen are starting up a new biomarkers co. for drug-induced toxicity. Release | Follow @JohnCFierce
@RyanMFierce: FierceBiotech IT lands in Philly for DIA summit, let me know how we're doing. More | Follow @RyanMFierce
> FDA rejects blockbuster Eliquis bid, asks Pfizer, BMS for trial clarification. News
> Price curmudgeons at NICE prep early-stage advice for VCs. Story
> Lexicon boasts of positive results in PhIIb diabetes study. Article
> Ventrus shares clobbered after failed PhIII forces it to regroup. Report
Medical Device News
@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev
@MarkHFierce: Yet another reason why device and Dx companies are turning to China. Item | Follow @MarkHFierce
@DamianFierce: Teleflex dropped $30M on an MIT spin-out for its safety-boosting device coating. Story | Follow @DamianFierce
> DSM closes $360M deal for Kensey Nash. More
> Arstasis draws $38M in new financing. Story
> St. Jude blames Durata lead failure on 'external abrasion.' Article
Biotech IT News
> Why Microsoft's Yammer buyout matters in pharma. Article
> Merck Serono, Compugen form startup to catch drug toxicity early. More
> Oracle rolls out cloud apps for clinical trial recruitment. Story
> Bay Area startup delivers clinical trials analytics from the cloud. News
And Finally... Living with a house dog may protect kids from a viral infection linked with asthma. Report